Symphony Neuro Development Company was a collaboration with Guilford Pharmaceuticals Inc.  Symphony Neuro was subsequently acquired by GliaMed, Inc.

Symphony Evolution, Inc. was a collaboration with Exelixis, Inc.  Symphony Evolution currently owns full rights to XL647, XL784 and XL999.

Symphony GenIsis, Inc. was a collaboration with Isis Pharmaceuticals, Inc.  Symphony GenIsis was acquired by Isis in September 2007.

Symphony Dynamo, Inc. was a collaboration with Dynavax Technologies Corporation.  Symphony Dynamo was acquired by Dynavax in November 2009.

Symphony Allegro, Inc. was a collaboration with Alexza Pharmaceuticals, Inc.  Symphony Allegro was acquired by Alexza in August 2009.

Symphony Icon, Inc. was a collaboration with Lexicon Pharmaceuticals, Inc.  Symphony Icon was acquired by Lexicon in August 2010.

Symphony ViDA, Inc. was a collaboration with OXiGENE, Inc.  Symphony ViDA was acquired by OXiGENE in July 2009.

 
Copyright 2002- © Symphony Capital LLC. All rights reserved.